A

Accretion Nutraveda Ltd.

SMEBSE
ListedListed on 4 Feb 2026+48.1%

₹122–129

₹ 18 Cr

2000 Shares

₹ 2,44,000

₹10

Financial Summary

Standalone(in ₹ million)
ParticularsFY 2025-26FY 2024-25
3,360.311,600.18
11.240.68
3,371.551,600.86
2,670.711,227.9
621.13315.33
506.83250.09

Subscription Details

Subscription data not yet available

IPO Timeline

IPO Offer Start

28 Jan 2026

IPO Offer Ends

30 Jan 2026

4 Feb 2026

Use of Proceeds

#PurposeAmount (₹ Million)
1General corporate purposes36.904

About the Company

Our Company is in the business of the Manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. We are a healthcare focused Company specialising in contract manufacturing, serving domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA. We offer a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. Since its inception in 2021, our Company has established itself as a reliable Contract Development and Manufacturing Organization (CDMO), offering specialized services to a wide range of clients across various industries. Our product portfolio includes Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support. We also manufacture Capsules, including hard gelatin and HPMC capsules, targeting areas like liver detoxification, women’s health, and cognitive support. Our oral liquids include syrups, suspensions, and tonics, which are particularly suited for paediatric and geriatric segments. Additionally, we produce Traditional Ayurvedic Powders known as churans for digestive health, medicated ayurvedic oils for musculoskeletal and dermatological applications using traditional processes, and a range of external preparations like balms, ointments, creams, and gels for pain relief, skin care, and hair care.

Use of Proceeds

1) Purchase of Machineries for Automation in existing Manufacturing unit 2) Purchase of Machineries for New Manufacturing Setup 3) Funding working capital requirements of our company; and 4) General corporate purposes

Accretion Nutraveda Ltd. Latest News

News

No news found for Accretion Nutraveda Ltd..

IPO FAQs

The Accretion Nutraveda Ltd. IPO has a total of ₹18 crore, calculated at the upper end of the .

The Accretion Nutraveda Ltd. IPO is priced at ₹122–129 per share. bids must fall within this , against a of ₹10 per share.

The for the Accretion Nutraveda Ltd. IPO is 2,000 shares, which is also the minimum order quantity — you have to apply for at least 2,000 shares, and in multiples of 2,000 beyond that.

The minimum investment in the Accretion Nutraveda Ltd. IPO is about ₹2,44,000 — one lot of 2,000 shares, calculated at the lower end of the .

Bidding at the cut-off or upper price raises the amount blocked in your account.

The Accretion Nutraveda Ltd. opens on 28 Jan 2026 and closes on 30 Jan 2026.

Applications have to be in before 5:00 PM IST on the closing day, and your UPI mandate needs to be approved by then as well.

Accretion Nutraveda Ltd. shares were listed on 4 Feb 2026 on BSE.

Accretion Nutraveda Ltd. IPO shares are listed on BSE.

Each Accretion Nutraveda Ltd. share has a of ₹10.

Face value is the nominal value recorded in the company's books and is separate from the issue price you pay.

1) Purchase of Machineries for Automation in existing Manufacturing unit 2) Purchase of Machineries for New Manufacturing Setup 3) Funding working capital requirements of our company; and 4) General corporate purposes

Pre-apply means placing your Accretion Nutraveda Ltd. application before the subscription window actually opens. The bid is held and forwarded to the exchange on the opening day, so you don't have to submit it in the rush of the first morning.

Applying early doesn't improve your chances — when an issue is oversubscribed, the for investors is decided by a lottery, not by who applied first. Your money is only blocked once the application reaches the exchange.

You can apply in the Accretion Nutraveda Ltd. IPO online using either UPI or ASBA as the payment method. ASBA applications are made through the net banking of a bank account that supports IPO applications — the bank blocks the amount in your account instead of debiting it. UPI applications are offered by brokers that don't provide banking services: you enter your UPI ID and then approve the mandate request in your UPI app.

Either route needs a demat account. You bid for at least one lot, at a price within the or at the cut-off price, and the money stays blocked in your bank account until the is finalised.

Your broker or bank confirms the bid once it has been submitted to the exchange, usually within a few minutes during the bidding window. A UPI application only goes live after you approve the mandate request — ignore it and the bid lapses, even though it looks placed.

You can check the Accretion Nutraveda Ltd. bid independently on the NSE or BSE IPO bid-verification page a day after applying. An ASBA application also shows up as a blocked amount in your bank statement.